Literature DB >> 712246

The sources of rat biliary cholesterol and bile acid.

T T Long, L Jakoi, R Stevens, S Quarfordt.   

Abstract

The precursor sources of bile acid and bile neutral sterol were evaluated in the rat using Triparanol to inhibit the terminal reduction in the synthesis of cholesterol. During the initial period of Triparanol administration, the accumulation of hepatic desmosterol acts to segregate relatively newly synthetic hepatic sterol from the bulk of the equilibrated sterol mass. Biliary excretion of newly synthetic sterol can then be determined in acute studies, assuming no great differences between desmosterol and cholesterol as precursors of biliary neutral sterol or bile acid. It has been determined in this model that newly synthetic sterol comprises a mean of about 28% of the total biliary neutral sterol output. This fraction fell when hepatic cholesterogenesis was suppressed by prior cholesterol feeding. By using this approach in conjunction with the administration of labeled mevalonate to a renal pedicle-ligated rat, it was possible to calculate the amount of bile acid produced from either newly synthesized sterol or the equilibrated sterol pool. It has been estimated that the bulk of bile acid synthesis arises from this equilibrated source when these determinations were made within two hours of creating the fistula. With more prolonged fistula times, more of the bile acid originated from the newly synthesized sterol.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 712246

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

1.  Heterogeneity of rat liver parenchyma in cholesterol 7 alpha-hydroxylase and bile acid synthesis.

Authors:  B Ugele; H J Kempen; J M Kempen; R Gebhardt; P Meijer; H J Burger; H M Princen
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Relationships between cholesterogenesis, microsomal sterols and HMG-CoA reductase in the perfused rat liver.

Authors:  E H Goh
Journal:  Lipids       Date:  1980-09       Impact factor: 1.880

Review 3.  Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.

Authors:  Helen H Wang; Piero Portincasa; Ornella de Bari; Kristina J Liu; Gabriella Garruti; Brent A Neuschwander-Tetri; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2013-02-19       Impact factor: 4.686

4.  Effects of Triton WR 1339 and orotic acid on lipid metabolism in rats.

Authors:  N Takeuchi; M Murase; Y Nomura; H Takase; K Uchida
Journal:  Lipids       Date:  1987-08       Impact factor: 1.880

5.  Glucagon lowers canine biliary cholesterol output at physiologic doses.

Authors:  B D Schirmer; W J Kortz; R J Miller; K G Christian; E Hayes; R S Jones
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

Review 6.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

7.  Increased biliary cholesterol secretion in alloxan diabetic mice.

Authors:  Y Ishikawa; K Uchida; T Akiyoshi
Journal:  Jpn J Surg       Date:  1984-03

8.  Transfer of exogenous cholesterol to microsomes of hepatocytes investigated with [3H]desmosterol tracer.

Authors:  E H Goh
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

9.  Movement of plasma-membrane sterols to the endoplasmic reticulum in cultured cells.

Authors:  J P Slotte; E L Bierman
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

10.  Evidence for distinct precursor pools for biliary cholesterol and primary bile acids in cebus and cynomolgus monkeys.

Authors:  Z F Stephan; K C Hayes
Journal:  Lipids       Date:  1985-06       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.